Sonoma Pharmaceuticals (SNOA) Financials: Revenue & Earnings
$5.60M
Market Cap
—
P/E
—
Forward P/E
—
Score
SNOA price $1.17 +0.03 +2.63%
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international…
Sonoma Pharmaceuticals, Inc. (SNOA) trades at $1.17, with a market cap of $5.60M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$5.60M
Market Cap
—
P/E
—
Forward P/E
—
Score